Summary
This document is a guide that outlines integrated solutions for vaccine innovation, specifically emphasizing real-world evidence (RWE) and market access strategies. It describes a team with over 30 years of experience in vaccine development and highlights their specialized knowledge in navigating the unique challenges faced by vaccine manufacturers. The guide details various approaches utilized, including patient preference studies, discrete choice experiments, and economic modeling, to support the development and market access of vaccines, particularly multi-valent vaccines. The document also presents case studies that illustrate the impact of their methodologies on vaccine market access during the COVID-19 pandemic, addressing challenges in stakeholder engagement and evidence requirements. Strategies for optimizing clinical development and post-marketing authorization processes are discussed, along with the importance of patient-centered research and health economics in informing market access strategies.
